Analysis Of Diagnostic, Classification, Activity And Severity Criteria In Systemic Sclerosis [análise Dos Critérios Diagnósticos, De Classificação, Atividade E Gravidade De Doença Na Esclerose Sistêmica]

dc.creatorFreire E.A.M.
dc.creatorCiconelli R.M.
dc.creatorSampaio-Barros P.D.
dc.date2004
dc.date2015-06-26T14:24:02Z
dc.date2015-11-26T14:12:37Z
dc.date2015-06-26T14:24:02Z
dc.date2015-11-26T14:12:37Z
dc.date.accessioned2018-03-28T21:13:17Z
dc.date.available2018-03-28T21:13:17Z
dc.identifier
dc.identifierRevista Brasileira De Reumatologia. , v. 44, n. 1, p. 40 - 45, 2004.
dc.identifier4825004
dc.identifier
dc.identifierhttp://www.scopus.com/inward/record.url?eid=2-s2.0-77956665552&partnerID=40&md5=642819281b45d6fe2602d509c6eda10c
dc.identifierhttp://www.repositorio.unicamp.br/handle/REPOSIP/94331
dc.identifierhttp://repositorio.unicamp.br/jspui/handle/REPOSIP/94331
dc.identifier2-s2.0-77956665552
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/1242055
dc.descriptionThe authors analyze the diagnostic and classification criteria in systemic sclerosis (SSc), the clinical variants diffuse and limited, and the recent concepts of SSc sine scleroderma and early SSc. It is also discussed the limitations in the validation of the methods to measure SSc activity and damage, and the recent efforts in order to standardize them.
dc.description44
dc.description1
dc.description40
dc.description45
dc.descriptionCurzio, C., Discussioni Anatomico-Pratiche Di Un Raro, E Stravagante Morbo Cutaneo in Una Giovanne Donna Felicemente Curato In Questo Grande Ospedale Degl'Incurabili, p. 1753. , Napoli, Giovanne di Simone
dc.descriptionBetschler, J.W., Induratio telae cellulosae (Scleroderma) (1832) Ann Klin Anstalt Univ Breslau, 1, pp. 209-210
dc.descriptionRodnan, G.P., Benedek, T.G., An historical account of the study of progressive systemic sclerosis (diffuse scleroderma) (1962) Ann Rheum Dis, 57, pp. 305-319
dc.descriptionMatsui, S., Uber die Pathologie und pathogenese von Sklerodermia universalis (1924) Mitt Med Fakult Kaiserl Univ Tokyo, 31, pp. 55-116
dc.descriptionKlemperer, P., Pollack, A.D., Baher, G., Diffuse collagen disease: Acute disseminated lupus erythematosus and diffuse scleroderma (1942) JAMA, 119, pp. 331-355
dc.descriptionGoetz, R.H., Pathology of progressive systemic sclerosis (generalized scleroderma) with special reference to changes in the viscera (1945) Clin Proc, 4, pp. 337-392
dc.descriptionLeroy, E.C., Black, C., Fleischmajer, R., Scleroderma (systemic sclerosis): Classification, subsets and pathogenesis (1988) J Rheumatol, 15, pp. 202-205
dc.descriptionMasi, A.T., Classification of systemic sclerosis (scleroderma): Relationship of cutaneous subgroups in early disease to outcome and serologic reactivity (1988) J Rheumatol, 15, pp. 894-898
dc.descriptionO'Leary, P.A., Nomland, R., A clinical study of one hundred and three cases of scleroderma (1930) Am J Med Sci, 180, pp. 95-112
dc.descriptionWinterbauer, R.H., Multiple telangiestasia, Raynaud ́s phenomenon, sclerodactily and subcutaneous calcinosis: A syndrome mimicking hereditary hemorrhagic telangiectasia (1964) Johns Hopkins Hosp Bull, 114, pp. 361-383
dc.descriptionCarr, R., Heisel, E.B., Stevenson, T.D., CRST syndrome: A benign variant of scleroderma (1965) Arch Dermatol, 92, pp. 519-525
dc.descriptionFritzler, M.J., Kinsella, T.D., Garbutt, E., The CREST syndrome: A distinct serologic entity with anticentromere antibodies (1980) Am J Med, 69, pp. 520-526
dc.descriptionMasi, A.T., Rodnan, G.P., Medsger Jr., T.A., Prelimianty criteria for the classification of systemic sclerosis (scleroderma) (1980) Arthritis Rheum, 23, pp. 581-590
dc.descriptionder Arbeitsgruppe, A.D.F., Klinik der progressiven systemichen sklerodermie (PSS): Multizentrische untersuchungen an 194 patienten (1986) Der Hautartz, 37, pp. 320-324
dc.descriptionGiordano, M., Valentini, G., Migliaresi, S., Piccillo, N., Vatti, M., Different antibody patterns and different prognoses in patients with scleroderma with various extent of skin sclerosis (1986) J Rheumatol, 13, pp. 911-916
dc.descriptionBarnett, A.J., Miller, M.H., Littlejohn, G.O., A survival study of patients with scleroderma diagnosed over 30 years (1953-1983): The value of a simple cutaneous classification in the early stages of the disease (1988) J Rheumatol, 15, pp. 276-283
dc.descriptionPoormoghim, H., Lucas, M., Fertig, N., Medsger Jr., T.A., Systemic sclerosis sine scleroderma: Demographic, clinical, and serologic features and survival in forty-eight patients (2000) Arthritis Rheum, 43, pp. 444-451
dc.descriptionLeroy, E.C., Medsger Jr., T.A., Criteria for the classification of early systemic sclerosis (2001) J Rheumatol, 28, pp. 1573-1576
dc.descriptionMedsger Jr., T.A., Bombardieri, S., Czirjak, L., Scorza, R., della Rossa, A., Bencivelli, W., Assessment of disease severity and prognosis (2003) Clin Exp Rheumatol, 21 (SUPPL. 29), pp. S42-S46
dc.descriptionFries, J.F., Hochberg, M.C., Medsger Jr., T.A., Criteria for rheumatic diseases: Different types and different functions (1994) Arthritis Rheum, 37, pp. 454-462
dc.descriptionMedsger Jr., T.A., Silman, A.J., Steen, V.D., A disease severity scale for systemic sclerosis: Development and testing (1999) J Rheumatol, 26, pp. 2159-2167
dc.descriptionValentini, G., Silman, A.J., Veale, D., Assessment of disease activity (2003) Clin Exp Rheumatol, 21 (SUPPL. 29), pp. S39-S41
dc.descriptionClements, P.J., Peter, J.B., Agopian, M.S., Elevated serum levels of soluble interleukin-2 receptor, interleukin-2 and neopterin in diffuse and limited scleroderma: Effects of chlorambucil (1990) J Rheumatol, 17, pp. 908-910
dc.descriptionStevens, W., Vancheeswaran, R., Black, C.M., Alpha-interferon-2a (Roferon-A) in the treatment of diffuse cutaneous scleroderma: A pilot study (1992) Br J Rheumatol, 31, pp. 683-689
dc.descriptionVeale, D.J., Fearon, U.M., Henshaw, W.K., Clinical and laboratory measures of disease activity in systemic sclerosis (2001) Arthritis Rheum, 44 (SUPPL.), pp. S327
dc.descriptionValentini, G., della Rossa, A., Bombardieri, S., European multicentre study to define disease activity criteria for systemic sclerosis II. Identification of disease activity variables and development of preliminary activity indexes (2001) Ann Rheum Dis, 60, pp. 592-598
dc.descriptionValentini, G., Bencivelli, W., Bombardieri, S., European Scleroderma Study Group to define disease activity criteria for systemic sclerosis. III. Assessment of the construct validity of the preliminary activity criteria (2003) Ann Rheum Dis, 62, pp. 901-903
dc.descriptionThe assessment of the patient with systemic sclerosis (2003) Clin Exp Rheumatol, 21 (SUPPL. 29), pp. S01-S56. , Valentini G, Medsger TA Jr, Silman AJ, Bombardieri S (Editores)
dc.descriptionFertig, N., Lucas, M., Feghali, C.A., Wright, T.M., Medsger Jr., T.A., Selected cytokines and soluble protein mediators as correlates of disease activity in systemic sclerosis with diffuse cutaneous involvement (2001) Arthritis Rheum, 44 (SUPPL.), pp. S327
dc.descriptionHu, P.Q., Fertig, N., Medsger Jr., T.A., Wright, T.M., Correlation of serum anti-DNA topoisomerase I antibody levels with disease activity in systemic sclerosis (2003) Arthritis Rheum, 48, pp. 1363-1373
dc.descriptionMerkel, P.A., Herlyn, K., Martin, R.W., Measuring disease activity and functional status in patients with scleroderma and Raynaud's phenomenon (2002) Arthritis Rheum, 46, pp. 2410-2420
dc.languagept
dc.publisher
dc.relationRevista Brasileira de Reumatologia
dc.rightsfechado
dc.sourceScopus
dc.titleAnalysis Of Diagnostic, Classification, Activity And Severity Criteria In Systemic Sclerosis [análise Dos Critérios Diagnósticos, De Classificação, Atividade E Gravidade De Doença Na Esclerose Sistêmica]
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución